In a prospective , double-blind , placebo-controlled , randomized study Lp-PLA2 , oxy-LDL , myeloperoxidase and interleukin-6 were determined at baseline , 3-5 days and 30 days during administration of omega-3 PUFA 1g/day ( n = 30 ) or placebo ( n = 24 ) .